Establishment of a concentration test method of S-071031B in rat plasma and its pharmacokinetics
Zhu Xiu-qin
Abstract
Zhu Xiu-qin
Abstract
Objective To establish an LC-MS/MS method for determination of S-071031B,a novel antidepressant,in rat plasma and to study its pharmacokinetic profiles. Methods An LC-MS / MS method was established to determine S-071031B in rat plasma,and L-8021 was employed as the internal standard. The analytes were separated on a C18column with a mobile phase consisting of water-acetonitrile containing 0. 1%( v / v) formic acid at a flow rate of 0. 3 ml / min. The mass spectrometer was operated in a selected reaction monitoring( SRM) mode with a positive electrospray ionization( ESI) interface. The plasma concentration-time curve was drawn and pharmacokinetic parameters were calculated by DAS2. 0. Results The linear range was from 2 to 1000 ng / ml with a sensitivity of 2 ng / ml as the lower limit of quantification.The intra-day and inter-day precisions,recoveries and matrix effects at three spiked levels were all suited to the determination of biological samples. After oral administration of S-071031B,the C max of S-071031B was( 287. 2 ± 50. 8) μg / L and the T max was( 0. 8 ± 0. 3) h,with a t1 /2of( 2. 9 ± 0. 6) h and an AUC( 0-∞)of( 1372. 6 ± 255. 3) μg / L·h. Conclusion This method is sensitive and specific enough for determination of S-071031B in rat plasma to facilitate the study of its pharmacokinetics.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To establish an LC-MS/MS method for determination of S-071031B,a novel antidepressant,in rat plasma and to study its pharmacokinetic profiles. Methods An LC-MS / MS method was established to determine S-071031B in rat plasma,and L-8021 was employed as the internal standard. The analytes were separated on a C18column with a mobile phase consisting of water-acetonitrile containing 0. 1%( v / v) formic acid at a flow rate of 0. 3 ml / min. The mass spectrometer was operated in a selected reaction monitoring( SRM) mode with a positive electrospray ionization( ESI) interface. The plasma concentration-time curve was drawn and pharmacokinetic parameters were calculated by DAS2. 0. Results The linear range was from 2 to 1000 ng / ml with a sensitivity of 2 ng / ml as the lower limit of quantification.The intra-day and inter-day precisions,recoveries and matrix effects at three spiked levels were all suited to the determination of biological samples. After oral administration of S-071031B,the C max of S-071031B was( 287. 2 ± 50. 8) μg / L and the T max was( 0. 8 ± 0. 3) h,with a t1 /2of( 2. 9 ± 0. 6) h and an AUC( 0-∞)of( 1372. 6 ± 255. 3) μg / L·h. Conclusion This method is sensitive and specific enough for determination of S-071031B in rat plasma to facilitate the study of its pharmacokinetics.
Key concepts: Pharmacokinetics, Chromatography, Chemistry, Electrospray ionization, Formic acid, Selected reaction monitoring, Mass spectrometry, Analytical Chemistry (journal)